TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

TG Therapeutics (TGTX) shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 19.6% loss over the past four weeks.This jump in share price came after management reported preliminary sales of its sole-marketed drug Briumvi for the full year 2024. TGTX claims to have added$ 310 million from the drug’s sales in 2024, surpassing management’s prior expectation of $30 ...